Who we are

We aim to improve the quality of life for everyone

Leadership & Scientific Advisors

HOME > Who we are > Leadership & Scientific Advisors

BIOCOZ GLOBAL is led and advised by well-recognized specialists.

World-renowned physicians and scientists from Harvard University, Massachusetts Institute of Technology, Korea University, and Severance Hospital are involved in the research and technology development of BIOCOZ GLOBAL. Our management team will be expanded further to include diverse experiences and knowledge of the industry.

Young Joon Kim

Chairman, Founder

Mr. Kim founded BIOCOZ GLOBAL and has served as CEO since the inception in 2006 until the end of 2018. He led the initial discovery and development efforts for our proprietary technology, SPM™. With an ambition to provide life-altering treatments to suffering patients with chronic skin diseases, he has initiated skin cell activator research at the Singapore National University Hospital with a team of stem cell and biotechnology scientists. Prior to BIOCOZ GLOBAL, Mr. Kim served as CEO at D2K and KS Marketing.

Mr. Kim founded BIOCOZ GLOBAL and has served as CEO since the inception in 2006 until the end of 2018. He led the initial discovery and development efforts for our proprietary technology, SPM™.
With an ambition to provide life-altering treatments to suffering patients with chronic skin diseases, he has initiated skin cell activator research at the Singapore National University of Singapore Hospital with a team of stem cell and biotechnology scientists. Prior to BIOCOZ GLOBAL, Mr. Kim served as CEO at D2K and KS Marketing.

Seung Jae Lee Ph.D.

CEO BIOCOZ GLOBAL Korea Corp.

Dr. Lee is a seasoned executive with 30 years of experience in the finance sector with a proven track record of building and managing financial and corporate strategy in both public and private organizations.
He has served as CEO of BIOCOZ GLOBAL Korea Corp. since Jan 2019. Prior to BIOCOZ GLOBAL Korea Corp., Dr. Lee has served as Executive Vice President at Samsung F&M Insurance. Prior to entering the private sector, Dr. Lee was at the Ministry of Finance, Asian Development Bank and the World Bank. He received his Ph.D. in Economics from the University of Missouri, Columbia.

Dr. Lee is a seasoned executive with 30 years of experience in the finance sector with a proven track record of building and managing financial and corporate strategy in both public and private organizations.
He has served as CEO of BIOCOZ GLOBAL Korea Corp. since Jan 2019. Prior to BIOCOZ GLOBAL Korea Corp., Dr. Lee has served as Executive Vice President at Samsung F&M Insurance. Prior to entering the private sector, Dr. Lee was at the Ministry of Finance, Asian Development Bank and the World Bank. He received his Ph.D. in Economics from the University of Missouri, Columbia.

Dr. Martin C. Mihm Jr.

Head of Medical Advisory Board

Dr. Mihm has been serving on the board since 2016. He is a world-renowned dermatopathologist and dermatologist who founded one of the first five residency training programs in Dermatopathology in the United States. He is the Director of Melanoma, Dermatology Department Brigham and Women's Hospital, Associate Director, Melanoma Program Dana-Farber and Brigham and Women's Cancer Center. He is also a professor of pathology and dermatology at Harvard Medical School and a co-director of the WHO melanoma pathology program. Dr. Mihm received his Doctor of Medicine degree from the University of Pittsburgh.

Dr. Mihm has been serving on the board since 2016. He is the world-renowned dermatopathologist and dermatologist who founded one of the first five residency training programs in Dermatopathology in the United States. He is the Director of Melanoma, Dermatology Department Brigham and Women's Hospital, Associate Director, Melanoma Program Dana-Farber and Brigham and Women's Cancer Center. He is also a professor of pathology and dermatology at Harvard Medical School and a co-director of the WHO melanoma pathology program. Dr. Mihm received his Doctor of Medicine degree from the University of Pittsburgh.

Anthony J. Sinskey Ph.D.

Head of Scientific Advisory Board

Dr. Sinskey has been serving on the board since 2015. He is a professor of Microbiology and Engineering Systems at the Massachusetts Institute of Technology (MIT). He also holds positions as co-director of the Malaysia-MIT Biotechnology Partnership Program and as the Faculty Director of the MIT Center for Biomedical Innovation.
Dr. Sinskey is well known in the biopharmaceutical industry and has been a scientific co-founder of several biotechnology companies, including Genzyme Corporation, Natural Pharmaceuticals, Metabolix, and Merrimack Pharmaceuticals. He received his Sc.D. in Microbiology and Food Science from the MIT.

Dr. Sinskey has been serving on the board since 2015. He is a professor of Microbiology and Engineering Systems at the Massachusetts Institute of Technology (MIT). He also holds positions as co-director of the Malaysia-MIT Biotechnology Partnership Program and as the Faculty Director of the MIT Center for Biomedical Innovation.
Dr. Sinskey is well known in the biopharmaceutical industry and has been a scientific co-founder of several biotechnology companies, including Genzyme Corporation, Natural Pharmaceuticals, Metabolix, and Merrimack Pharmaceuticals. He received his Sc.D. in Microbiology and Food Science from the MIT.

Chanwha Kim Ph.D.

Chief Science Officer & CTO

Dr. Kim has served as our Chief Science Officer and Chief Technology Officer since 2011. He brings almost thirty years of experience in biotechnology to BIOCOZ GLOBAL.
Dr. Kim has been a professor of biotechnology since 1995, and a chief technology officer of the Institute of Life Science and Biotechnology at Korea University since 2005. Prior to his career at the university, Dr. Kim was Director at XGen Corp, Principal Research Engineer at 3M Co., Technical Advisor at Genzyme Corp. and Senior Researcher at ATC Diagnostics Inc. Dr. Kim received his Ph.D. in biotechnology from the MIT.

Dr. Kim has served as our Chief Science Officer and Chief Technology Officer since 2011. He brings almost thirty years of experience in biotechnology to BIOCOZ GLOBAL.
Dr. Kim has been a professor of biotechnology since 1995, and a chief technology officer of the Institute of Life Science and Biotechnology at Korea University since 2005. Prior to his career at the university, Dr. Kim was Director at XGen Corp, Principal Research Engineer at 3M Co., Technical Advisor at Genzyme Corp. and Senior Researcher at ATC Diagnostics Inc. Dr. Kim received his Ph.D. in biotechnology from the MIT.

Kevin L. Ohashi Ph.D.

Member of Science Advisory Board

Dr. Ohashi joined the board in 2015. He is a seasoned life science entrepreneur and venture capitalist. His experience spans a large segment of healthcare, including sports medicine, device manufacturing and regenerative medicine.
He is the founder of Pond Capital, LLC., Cayenne Medical, nContact, and Tauten Sports. He also serves directing roles at MicroVascular Tissues, Tauten, and OC 10. Dr. Ohashi holds a Ph.D. Minor in Materials Science Engineering and a Ph.D. in Mechanical Engineering from Stanford.

Dr. Ohashi joined the board in 2015. He is a seasoned life science entrepreneur and venture capitalist. His experience spans a large segment of healthcare, including sports medicine, device manufacturing and regenerative medicine.
He is the founder of Pond Capital, LLC., Cayenne Medical, nContact, and Tauten Sports. He also serves directing roles at MicroVascular Tissues, Tauten, and OC 10. Dr. Ohashi holds a Ph.D. Minor in Materials Science Engineering and a Ph.D. in Mechanical Engineering from Stanford.

Dr. Ju Hee Lee

Member of Medical Advisory Board

Dr. Lee is a professor and the chairman of department of Dermatology, Yonsei University College of Medicine, head of department of Dermatology at Severance Hospital, director of Cutaneous Biology Research Institute, and director of Scar Laser & Plastic Surgery Center, Yonsei Cancer Hospital.
Dr. Lee is an active member of several medical professional organizations, including the Academic Committee of Korean Society of Dermatology, Korean Society of Dermatology and Korean Society of Cosmetic Dermatology. Dr. Lee received her Doctor of Medicine degree from Yonsei University.

Dr. Lee is a professor and the chairman of department of Dermatology, Yonsei University College of Medicine, head of department of Dermatology at Severance Hospital, director of Cutaneous Biology Research Institute, and director of Scar Laser & Plastic Surgery Center, Yonsei Cancer Hospital.
Dr. Lee is an active member of several medical professional organizations, including the Academic Committee of Korean Society of Dermatology, Korean Society of Dermatology and Korean Society of Cosmetic Dermatology. Dr. Lee received her Doctor of Medicine degree from Yonsei University.

Dr. Byung Gun Kim

Member of Medical Advisory Board

Dr. Kim is the director of BK Plastic Surgery Hospital Korea and BK Medical Group Aesthetic Clinic Singapore. He is also a key opinion leader and investor in the field of biotechnology.
Since joining the board in 2017, he has been bringing his rich experience as a plastic surgeon to the company. Dr. Kim received his Doctor of Medicine degree from Seoul National University.

Dr. Kim is the director of BK Plastic Surgery Hospital Korea and BK Medical Group Aesthetic Clinic Singapore. He is also a key opinion leader and investor in the field of biotechnology.
Since joining the board in 2017, he has been bringing his rich experience as a plastic surgeon to the company. Dr. Kim received his Doctor of Medicine degree from Seoul National University.